| Filed On | Filing |
|---|---|
| 07 Jan 2026 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This Employment Agreement (this “Agreement”) is made by and between Centessa Pharmaceuticals (UK) Limited (referred to herein as the “Company”) and Mario Alberto Accardi (the “Executive”) on 5 January, 2026 and is effective as of 1 Janua... |
| 14 Mar 2022 |
8-K/A: Unregistered Sales of Equity Securities; Regulation FD Disclosure
BOSTON and LONDON, February 24, 2022 – Centessa Pharmaceuticals plc (Nasdaq: CNTA) (the “Company”), together with its subsidiary Palladio Biosciences, Inc. (“Palladio”), today announced it has started dosing of the first subject in its p... |
Loading...